Solantic schedules ribbon-cutting ceremony for new walk-in clinic location
POMPANO BEACH, Fla. Solantic, a provider of walk-in urgent care centers across Florida, has announced the opening of a new center in Pompano Beach.
A grand opening event for the full-service walk-in urgent care center will take place Oct. 16. Pompano Beach vice mayor George Brummer will be on hand to cut the ribbon.
The centers are staffed by physicians and are open extended hours. The services include urgent care, x-rays, immunizations, blood work and physicals as well as occupational health services like work-related injuries and drug screens.
This new facility marks the company’s third center in Broward County, with additional clinics located in Coconut Creek and Pembroke Pines. A fourth location is slated to open Nov. 3 in Tamarac. The company currently operates eight centers in North Florida, seven in Central Florida and two on the Treasure Coast.
The centers are part of an expansion plan throughout the state with 20 centers presently open and an expected 1,000 locations nationwide over the next few years.
Walgreens reports increase in sales for September
DEERFIELD, Ill. Walgreens today reported that its sales for the month of September totaled $4.85 billion, up 10 percent from the same month last year. Calendar year-to-date, sales totaled $44.35 billion reflecting an increase of 9.9 percent from last year’s total of $40.36 billion.
The company also said that comparable-store sales, covering stores open for at least one year, increased by 4.7 percent. Front-end comp-store sales increased 1.3 percent, the company reported. Walgreens credited front-end sales numbers to strong beauty and consumables sales.
According to Walgreens, pharmacy sales comprised 67.2 percent of total sales for September. September pharmacy sales increased 11.2 percent, while comparable pharmacy sales increased 6.5 percent. Comparable pharmacy sales were negatively impacted by 2.4 percentage points due to generic drug introductions in the last 12 months. Total prescriptions filled at comparable stores increased 3.5 percent.
In September, Walgreens cut the ribbon on 36 stores, including three relocations, and acquired three stores.
FDA approves new treatment for HIV
PRINCETON, N.J. The Food and Drug Administration has approved a new combination therapy for HIV from Bristol-Myers Squibb, Bristol announced Wednesday.
The treatment, which combines 300 mg of the drug Reyataz (atazanavir sulfate) with 100 mg of ritonavir, is for people with untreated HIV, also known as treatment-naive patients.
“Boosted Reyataz provides healthcare professionals a newly approved, once-daily dosing option as part of combination therapy for patients naive to HIV therapy,” said Dr. Elliott Sigal, Bristol’s executive vice president, chief scientific officer and president for research and development.
The treatment is based on the 48-week CASTLE study, which demonstrated that the once-daily combined therapy was similar in efficacy to the twice-daily combination of lopinavir and ritonavir.